These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 15588901)

  • 1. Transmucosal macromolecular drug delivery.
    Prego C; García M; Torres D; Alonso MJ
    J Control Release; 2005 Jan; 101(1-3):151-62. PubMed ID: 15588901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery.
    Garcia-Fuentes M; Prego C; Torres D; Alonso MJ
    Eur J Pharm Sci; 2005 May; 25(1):133-43. PubMed ID: 15854809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules.
    Teijeiro-Osorio D; Remuñán-López C; Alonso MJ
    Biomacromolecules; 2009 Feb; 10(2):243-9. PubMed ID: 19117404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
    Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
    Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
    Rekha MR; Sharma CP
    J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination.
    Borges O; Cordeiro-da-Silva A; Romeijn SG; Amidi M; de Sousa A; Borchard G; Junginger HE
    J Control Release; 2006 Sep; 114(3):348-58. PubMed ID: 16905219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanosized insulin-complexes based on biodegradable amine-modified graft polyesters poly[vinyl-3-(diethylamino)-propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft-poly(L-lactic acid): protection against enzymatic degradation, interaction with Caco-2 cell monolayers, peptide transport and cytotoxicity.
    Simon M; Behrens I; Dailey LA; Wittmar M; Kissel T
    Eur J Pharm Biopharm; 2007 May; 66(2):165-72. PubMed ID: 17150341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
    Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
    J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules.
    Goycoolea FM; Lollo G; Remuñán-López C; Quaglia F; Alonso MJ
    Biomacromolecules; 2009 Jul; 10(7):1736-43. PubMed ID: 19545119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
    Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q
    Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
    Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A
    Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree.
    Prego C; Torres D; Fernandez-Megia E; Novoa-Carballal R; Quiñoá E; Alonso MJ
    J Control Release; 2006 Apr; 111(3):299-308. PubMed ID: 16481062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
    Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
    Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan-aprotinin coated liposomes for oral peptide delivery: Development, characterisation and in vivo evaluation.
    Werle M; Takeuchi H
    Int J Pharm; 2009 Mar; 370(1-2):26-32. PubMed ID: 19073243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery.
    Prego C; Fabre M; Torres D; Alonso MJ
    Pharm Res; 2006 Mar; 23(3):549-56. PubMed ID: 16525861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioadhesive nanoparticles of fungal chitosan for oral DNA delivery.
    Plapied L; Vandermeulen G; Vroman B; Préat V; des Rieux A
    Int J Pharm; 2010 Oct; 398(1-2):210-8. PubMed ID: 20674728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal delivery of liposome-chitosan nanoparticle complexes.
    Carvalho EL; Grenha A; Remuñán-López C; Alonso MJ; Seijo B
    Methods Enzymol; 2009; 465():289-312. PubMed ID: 19913173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin.
    Chen MC; Wong HS; Lin KJ; Chen HL; Wey SP; Sonaje K; Lin YH; Chu CY; Sung HW
    Biomaterials; 2009 Dec; 30(34):6629-37. PubMed ID: 19767097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin.
    Garcia-Fuentes M; Torres D; Alonso MJ
    Int J Pharm; 2005 May; 296(1-2):122-32. PubMed ID: 15885464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.